Concord Healthcare Schedules 11 May 2026 AGM; Proposes 20% Issuance Mandate, 10% Buyback Limit and No Final Dividend

Bulletin Express
04/15

Concord Healthcare Group Co., Ltd. will convene its Annual General Meeting (AGM) for the 2025 financial year on 11 May 2026 at 9:30 a.m. (Hong Kong time) at A1, 26th Floor, Hanwei Building East Area, No. 7 Guanghua Road, Chaoyang District, Beijing.

Key ordinary resolutions • Approval of the 2025 Directors’ Report, 2025 Annual Report and 2025 Environmental, Social and Governance Report. • Confirmation of directors’ remuneration for 2025 and proposed remuneration for 2026. • Re-appointment of the external auditor. • Endorsement of the 2025 Annual Results Announcement and related authorisations. • Appointment of an additional executive director and approval of that director’s 2026 remuneration. • No final dividend for the year ended 31 December 2025.

Key special resolutions • General mandate authorising the Board to issue, allot and/or deal with additional Domestic and/or H Shares up to 20% of the shares in issue as at the AGM date, capped at 156.73 million shares. • General mandate authorising the Board to repurchase H Shares on the Hong Kong Stock Exchange up to 10% of the H Shares in issue during the mandate period. The mandates will remain effective until the earlier of (i) the next AGM, (ii) 12 months after approval, or (iii) revocation by shareholders.

Shareholder arrangements • The H-share register will be closed from 6 May 2026 to 11 May 2026 (both days inclusive). Share transfers must be lodged with Computershare Hong Kong Investor Services Limited by 4:30 p.m. on 5 May 2026 to qualify for AGM attendance and voting. • Shareholders may appoint one or more proxies to vote by poll; completed proxy forms must be received at the designated addresses not less than 24 hours before the meeting.

Board composition at the notice date: Executive Directors – Dr. Yang Jianyu (Chairman), Ms. Fu Xiao, Mr. Chang Liang; Non-executive Directors – Mr. Wang Lei, Mr. Song Qingbao, Mr. Shi Botao; Independent Non-executive Directors – Ms. Li Xuemei, Mr. Sun Yansheng, Mr. Ng Kwok Yin.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10